BofA analyst Tazeen Ahmad downgraded SQZ Biotechnologies to Underperform from Buy with a price target of $2, down from $9.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SQZ:
BofA analyst Tazeen Ahmad downgraded SQZ Biotechnologies to Underperform from Buy with a price target of $2, down from $9.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SQZ: